Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment

被引:227
作者
Ju, Zhenyu
Jiang, Hong
Jaworski, Maike
Rathinam, Chozhavendan
Gompf, Anne
Klein, Christoph
Trumpp, Andreas
Rudolph, K. Lenhard [1 ]
机构
[1] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany
[2] Ecole Polytech Fed Lausanne, Genet & Stem Cell Lab, Swiss Inst Expt Canc Res, ISREC,Sch Life Sci, CH-1015 Lausanne, Switzerland
[3] Hannover Med Sch, Dept Pediat Hematol & Oncol, D-30625 Hannover, Germany
关键词
D O I
10.1038/nm1578
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cell-intrinsic checkpoints limit the proliferative capacity of primary cells in response to telomere dysfunction. It is not known, however, whether telomere dysfunction contributes to cell-extrinsic alterations that impair stem cell function and organ homeostasis. Here we show that telomere dysfunction provokes defects of the hematopoietic environment that impair B lymphopoiesis but increase myeloid proliferation in aging telomerase knockout (Terc(-/-)) mice. Moreover, the dysfunctional environment limited the engraftment of transplanted wild-type hematopoietic stem cells (HSCs). Dysfunction of the hematopoietic environment was age dependent and correlated with progressive telomere shortening in bone marrow stromal cells. Telomere dysfunction impaired mesenchymal progenitor cell function, reduced the capacity of bone marrow stromal cells to maintain functional HSCs, and increased the expression of various cytokines, including granulocyte colony-stimulating factor (G-CSF), in the plasma of aging mice. Administration of G-CSF to wild-type mice mimicked some of the defects seen in aging Terc(-/)-mice, including impairment of B lymphopoiesis and HSC engraftment. Conversely, inhibition of G-CSF improved HSC engraftment in aged Terc(-/)-mice. Taken together, these results show that telomere dysfunction induces alterations of the environment that can have implications for organismal aging and cell transplantation therapies.
引用
收藏
页码:742 / 747
页数:6
相关论文
共 30 条
  • [1] The hematopoietic stem cell in its place
    Adams, GB
    Scadden, DT
    [J]. NATURE IMMUNOLOGY, 2006, 7 (04) : 333 - 337
  • [2] Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation
    Allsopp, RC
    Morin, GB
    DePinho, R
    Harley, CB
    Weissman, IL
    [J]. BLOOD, 2003, 102 (02) : 517 - 520
  • [3] Aging, longevity, inflammation, and cancer
    Caruso, C
    Lio, D
    Cavallone, L
    Franceschi, C
    [J]. SIGNAL TRANSDUCTION AND COMMUNICATION IN CANCER CELLS, 2004, 1028 : 1 - 13
  • [4] Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation
    Choudhury, Aaheli Roy
    Ju, Zhenyu
    Djojosubroto, Meta W.
    Schienke, Andrea
    Lechel, Andre
    Schaetzlein, Sonja
    Jiang, Hong
    Stepczynska, Anna
    Wang, Chunfang
    Buer, Jan
    Lee, Han-Woong
    von Zglinicki, Thomas
    Ganser, Arnold
    Schirmacher, Peter
    Nakauchi, Hiromitsu
    Rudolph, K. Lenhard
    [J]. NATURE GENETICS, 2007, 39 (01) : 99 - 105
  • [5] Rejuvenation of aged progenitor cells by exposure to a young systemic environment
    Conboy, IM
    Conboy, MJ
    Wagers, AJ
    Girma, ER
    Weissman, IL
    Rando, TA
    [J]. NATURE, 2005, 433 (7027) : 760 - 764
  • [6] d'Adda diFagagna F., 2003, Nature, V426, P194, DOI DOI 10.1038/NATURE02118
  • [7] Werner syndrome as an example of inflamm-aging: Possible therapeutic opportunities for a progeroid syndrome?
    Davis, Terence
    Kipling, David
    [J]. REJUVENATION RESEARCH, 2006, 9 (03) : 402 - 407
  • [8] Djojosubroto MW, 2003, MOL CELLS, V15, P164
  • [9] DRIZE N, 1993, EXP HEMATOL, V21, P1289
  • [10] Hardy Richard R, 2004, Methods Mol Biol, V271, P1